tiprankstipranks
Trending News
More News >
BioArctic AB Class B (SE:BIOA.B)
:BIOA.B

BioArctic AB Class B (BIOA.B) Price & Analysis

Compare
1 Followers

BIOA.B Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.45%97.00%
Insiders
1.45%
Mutual Funds
― Other Institutional Investors
97.00% Public Companies and
Individual Investors

BIOA.B FAQ

What was BioArctic AB Class B’s price range in the past 12 months?
BioArctic AB Class B lowest stock price was kr137.70 and its highest was kr271.40 in the past 12 months.
    What is BioArctic AB Class B’s market cap?
    BioArctic AB Class B’s market cap is kr17.81B.
      When is BioArctic AB Class B’s upcoming earnings report date?
      BioArctic AB Class B’s upcoming earnings report date is Aug 28, 2025 which is in 78 days.
        How were BioArctic AB Class B’s earnings last quarter?
        BioArctic AB Class B released its earnings results on May 21, 2025. The company reported kr11.55 earnings per share for the quarter, beating the consensus estimate of kr10.42 by kr1.13.
          Is BioArctic AB Class B overvalued?
          According to Wall Street analysts BioArctic AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BioArctic AB Class B pay dividends?
            BioArctic AB Class B pays a Notavailable dividend of kr1.5 which represents an annual dividend yield of N/A. See more information on BioArctic AB Class B dividends here
              What is BioArctic AB Class B’s EPS estimate?
              BioArctic AB Class B’s EPS estimate is 1.26.
                How many shares outstanding does BioArctic AB Class B have?
                BioArctic AB Class B has 74,128,490 shares outstanding.
                  What happened to BioArctic AB Class B’s price movement after its last earnings report?
                  BioArctic AB Class B reported an EPS of kr11.55 in its last earnings report, beating expectations of kr10.42. Following the earnings report the stock price went up 11.027%.
                    Which hedge fund is a major shareholder of BioArctic AB Class B?
                    Currently, no hedge funds are holding shares in SE:BIOA.B

                    Company Description

                    BioArctic AB Class B

                    BioArctic AB (publ), a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, which is in Phase III clinical trials targeting the toxic amyloid-beta oligomers/protofibrils in Alzheimer's disease; and is in preclinical trials for treating Down's syndrome with dementia and traumatic brain injury, as well as BAN2401 Back-up, a disease modifying antibody treatment that is in late preclinical Phase for patients with early Alzheimer's disease. It also develops ABBV-0805, a monoclonal antibody for treating Parkinson's disease; and SC0806, a biodegradable device that is in Phase I/II clinical trial for spinal cord injuries. In addition, the company develops imaging and biochemical biomarkers for Alzheimer's and Parkinson's disease; and blood-brain-barrier technology that enables the passage of antibodies and other substances into the brain through the blood brain barrier, as well as focuses on developing ND3014 antibodies for treating neurodegenerative disorders; AD1801, AD1502, AD1503, AD-BT2802, AD-BT2803, and AD2603 for the treatment of Alzheimer's disease; and PD1601 and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was founded in 1992 and is based in Stockholm, Sweden.
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Hansa Biopharma AB
                    BioInvent International AB
                    Vicore Pharma Holding AB
                    InDex Pharmaceuticals Holding AB
                    Xspray Pharma AB
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis